• Increase font size
  • Default font size
  • Decrease font size
home | about us | contact us
Search
Search Only:

Search Keyword imedicor

Total: 22 results found.

... company specializing in products for cancer and supportive care, today announced its e-marketing partner, iMedicor (OTC Bulletin Board:VMCI.ob) commenced the initial phase of a multi-channel marketing ...
... announced its e-marketing partner, iMedicor (OTC Bulletin Board: VMCI) commenced the initial phase of a multi-channel marketing program for MuGard.  iMedicor's two-pronged marketing approach involves ...
... to the patient population of the SunCoast region while minimizing costs through creative programs, partnerships, and technology; such as iMedicor's Clear Lobby, that ultimately will benefit all participants ...
... and clinical integration software to the medical community announced today a partnership with iMedicor (OTCBB: VMCI). Medtronic, Inc. (NYSE: MDT), today announced completion of patient enrollment ...
... a partnership with iMedicor (OTCBB: VMCI). The partnership will provide a natural synergy of combined solutions that will enable enhanced information exchange capabilities to increase the efficacy ...
... Receptor (TLR) 7 and TLR9. iMedicor (OTCBB: VMCI) today announced it has received $750,000 in bridge funding from a private investment group and has received expressions of interest from other investors ...
NANUET, N.Y.--iMedicor (OTCBB: VMCI) today announced it has received $750,000 in bridge funding from a private investment group and has received expressions of interest from other investors to expand ...
... for fourth quarter and full year 2009 on Thursday, March 4, 2010, after market close. iMedicor (OTCBB: VMCI) today announced that it has entered into a strategic alliance with MedTrust Online, a portal ...
NANUET, N.Y.--iMedicor (OTCBB: VMCI) today announced that it has entered into a strategic alliance with MedTrust Online, a portal that helps cancer doctors practice the most precise medicine for their ...
... shine some light on the advantages of MuGard as both a preventative and curative option for OM. In addition, Access signed an e-Marketing deal with iMedicor (OTC: VMCI.OB) in early October as a cost-efficient ...
... in conjunction with the availability of initial product inventory by its liquid contract manufacturing partner, Accupac. In addition, Access signed an e-Marketing deal with iMedicor (OTC: VMCI.OB) ...
12. RxNews Recap on Monday 11-02-09
(Home Page/Home Page)
... WebSDM™ Release 3.0 software, including the Empirica™ Study Clinical Trials Signal Detection system. iMedicor (OTC:VMCI) announced it has received a Scope of Work (SOW) order from its partner, Franklyn ...
... for licensing the rights to MuGard in North America and the pending U.S. commercial launch in conjunction with the contract manufacturing agreement with Accupac and the eMarketing agreement with iMedicor; ...
... in Europe, and possibly the U.S. as compared to an indication for colorectal cancer. The e-Marketing / oncologist education deal with iMedicor announced earlier this month and pending domestic MuGard ...
Access Pharma (OTC: ACCP.OB) announced an e-Marketing deal today with iMedicor (OTC: VMCI.OB) for the commercial launch of MuGard through the latter’s targeted marketing / education Alerts System application ...
... ulcers, such as those caused by oral surgery.Marketing/Sales:Access has signed a deal with iMedicor to support online eMarketing efforts and education of oncologists, radiation oncologist and support staff ...
NANUET, N.Y.--(BUSINESS WIRE)--iMedicor, (OTCBB: VMCI), today announced that Chief Executive Officer Fred Zolla and President, Tom Dorsett will speak to the company's shareholders on Thursday, Noember ...
NANUET, N.Y.--iMedicor (OTCBB:VMCI) today announced it has received a Scope of Work (SOW) order from its partner, Franklyn Ideas, LLC (Franklyn) on behalf of one of its major pharmaceutical clients. ...
NANUET, N.Y.--iMedicor (OTCBB: VMCI) today announced it has signed an agreement with Dallas-based Access Pharmaceuticals (OTCBB: ACCP) for the North American commercial launch of MuGard, its FDA-approved ...
NANUET, N.Y.--iMedicor (OTCBB: VMCI) today announced the successful completion of the pilot project of its first direct-to-pharmacy, electronic prescription refill technology via its HIPAA compliant ...
NANUET, N.Y.--iMedicor, (OTCBB:VMCI), today announced that Chief Executive Officer Fred Zolla will address the company’s shareholders on Thursday August 6, 2009 beginning at 12:00 PM, EST. Mr. Zolla’s ...
NANUET, N.Y.---iMedicor, (OTCBB:VMCI), today announced that Chief Executive Officer Fred Zolla will address the company’s shareholders on Thursday August 6, 2009 beginning at 12:00 PM, EST. Mr. Zolla’s ...

Get Free Email and Phone News Alerts

* Your email address:
* Preferred Format:
* Enter the security code shown:
 
Home | Privacy Policy
© 2010 BioMedReports.com. All rights reserved